The Costa Rican health-tech expands to Mexico to help prevent blindness.
Ainnova Tech expanded to Mexico from Costa Rica to help prevent blindness from diabetic retinopathy. The Costa Rican health-tech uses artificial intelligence to detect diabetic retinopathy in time.
The company's arrival in Mexico came through Startup México's SoftLanding program, bringing accessible early detection to a larger population.
Ainnova's arrival in Mexico came through the SoftLanding program of Startup México, which helps companies from across Latin America enter the Mexican market with mentorship, business contacts and access to investment.
Mexico's large population living with diabetes makes accessible retinal screening especially impactful.
Ainnova Tech is a healthcare technology company focused on revolutionizing early disease detection using artificial intelligence. Its platform, VisionAI, analyzes retinal images to detect early markers of diseases such as diabetic retinopathy — with a growing portfolio spanning cardiovascular, metabolic, liver and kidney risk. Ainnova is dedicated to making healthcare more proactive, accessible and efficient.
Source: Reported by Bloomberg Línea ↗
Contact: Ainnova Tech — info@ainnovatech.com